Human Metapneumovirus Diagnostics Global Market Report 2025
상품코드:1760555
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 175 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
인간 메타뉴모바이러스 진단 시장 규모는 향후 몇 년 동안 10.1%의 연평균 성장률을 기록하며 2029년에는 7억 9,000만 달러 규모로 성장할 것으로 예상됩니다. 예측 기간 동안 예상되는 성장은 조기 및 정확한 호흡기 감염 진단에 대한 수요 증가, 현장 진단 솔루션에 대한 투자 확대, 신흥 시장에서의 의료 접근성 확대, 팬데믹 대응에 대한 전 세계적인 관심, 다중 호흡기 패널의 통합 확대 등이 배경이 될 것으로 예상됩니다. 배경입니다. 예측 기간의 주요 동향으로는 자동화 및 고처리량 진단 시스템 개발, 분산형 진단 모델로의 전환, 진단 해석에 인공지능 활용, 재택 검사 키트 채택 확대, 상장사와 비상장사의 협력 관계 확대 등을 꼽을 수 있습니다.
호흡기 감염증의 증가는 인간 메타뉴모바이러스 진단제 시장의 성장을 촉진할 것으로 예상됩니다. 바이러스, 박테리아 및 기타 병원체에 의한 호흡기 감염은 부비동, 인두, 기도 및 폐를 포함한 호흡기 계통에 영향을 미칩니다. 유병률의 증가는 유해한 오염물질에 대한 노출이 호흡기를 자극하고 약화시켜 감염에 취약하게 만드는 것과 관련이 있는 것으로 생각됩니다. 인간메타뉴모바이러스 진단약은 호흡기 감염증의 원인으로 hMPV를 식별하여 정확한 치료와 더 나은 관리를 가능하게 합니다. 예를 들어, 2025년 1월 영국 보건안전국은 2023-2024년 시즌 동안 영국의 호흡기 감염률이 2023년 50주와 52주에 10만 명당 8명으로 정점을 찍고, 2024년 4주에는 10만 명당 10.2명으로 더 높아질 것으로 예상했습니다.에서의 급성 호흡기 감염 발생 건수는 2,051건에 이르렀으며, 대부분의 사례가 요양시설과 병원에서 보고되었다고 보고했습니다. 이러한 호흡기 감염증의 확산은 인간메타뉴모바이러스 진단제 시장 확대에 박차를 가하고 있습니다.
인간 메타뉴모바이러스 진단제 시장의 주요 기업들은 호흡기 중합효소 연쇄 반응(PCR) 진단 도구와 같은 혁신적인 솔루션 개발에 집중하며 다양한 호흡기 병원체를 검출하는 분자진단 역량을 강화하고 있습니다. 호흡기 PCR 진단 솔루션은 호흡기 병원체의 유전물질을 고감도, 고특이성으로 증폭하여 검출 및 동정하는 분자 검사법입니다. 예를 들어, 2023년 3월 중국 소재 분자진단 회사인 Jiangsu BioPerfectus Technologies Co, Ltd.는 호흡기 병원체 다중 실시간 PCR 진단 키트를 출시하였습니다. 이 솔루션은 여러 호흡기 병원체를 동시에 높은 정확도로 신속하게 검출할 수 있도록 설계되어 임상 현장과 진료 현장에서 진단 효율을 향상시킵니다. 광범위한 적용 범위와 정확한 성능은 특히 증상이 중복되는 호흡기 감염증의 관리에서 적시에 임상적 의사결정을 내리는 데 큰 도움이 될 것입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 인간 메타뉴모바이러스 진단 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 인간 메타뉴모바이러스 진단 시장 : 성장률 분석
세계의 인간 메타뉴모바이러스 진단 시장 실적 : 규모와 성장, 2019-2024년
세계의 인간 메타뉴모바이러스 진단 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 인간 메타뉴모바이러스 진단 전체 시장(TAM)
제6장 시장 세분화
세계의 인간 메타뉴모바이러스 진단 시장 : 제품 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
시약과 키트
기기
세계의 인간 메타뉴모바이러스 진단 시장 : 테스트 유형별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
분자진단
면역진단
배양 기반 방법
기타 테스트 종류
세계의 인간 메타뉴모바이러스 진단 시장 : 기술별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
PCR 기반 진단
차세대 시퀀싱(NGS)
면역형광 어세이
측방유동 어세이
마이크로어레이 기술
기타 첨단 기술
세계의 인간 메타뉴모바이러스 진단 시장 : 최종 용도별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
병원과 진료소
진단 및 참조 검사실
학술연구기관
기타 최종사용자
세계의 인간 메타뉴모바이러스 진단 시장, 시약과 키트 종류별 하위 세분화, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
샘플 채취 키트
핵산 추출 키트
바이러스 운송 매체
컨트롤 시약
세계의 인간 메타뉴모바이러스 진단 시장, 기기 종류별 하위 세분화, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
서멀 사이클러
자동 분석기
핵산 추출 장비
형광 리더
제7장 지역별·국가별 분석
세계의 인간 메타뉴모바이러스 진단 시장 : 지역별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 인간 메타뉴모바이러스 진단 시장 : 국가별, 실적과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
인간 메타뉴모바이러스 진단 시장 : 경쟁 구도
인간 메타뉴모바이러스 진단 시장 : 기업 개요
F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
QuidelOrtho Corporation
Bio-Rad Laboratories Inc.
ARUP Laboratories
Qiagen NV
Diasorin
Luminex Corporation
bioMerieux
Seegene Inc.
Cepheid
R-Biopharm AG
Certest Biotec
ZeptoMetrix
Xi'an Tianlong Science and Technology Co. Ltd
The Native Antigen Company
Hangzhou Testsea Biotechnology Co. Ltd.
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
인간 메타뉴모바이러스 진단 시장 2029년 : 새로운 기회를 제공하는 국가
인간 메타뉴모바이러스 진단 시장 2029년 : 새로운 기회를 제공하는 부문
인간 메타뉴모바이러스 진단 시장 2029년 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
ksm
영문 목차
영문목차
Human metapneumovirus (hMPV) diagnostics involve the methods and criteria used to detect and confirm infection with human metapneumovirus, a respiratory pathogen that can cause illnesses ranging from mild cold-like symptoms to severe respiratory infections, particularly in children, the elderly, and immunocompromised individuals.
The primary product types in human metapneumovirus diagnostics are reagents and kits, as well as instruments. Reagents and kits are essential laboratory products that contain chemical substances and tools for performing specific diagnostic tests or experiments. The diagnostic test types include molecular diagnostics, immunodiagnostics, culture-based methods, and others, utilizing technologies such as PCR-based diagnostics, next-generation sequencing (NGS), immunofluorescence assays, lateral flow assays, microarray technology, and others. These tests are used in various settings, including hospitals and clinics, diagnostic and reference laboratories, academic and research institutions, among others.
The human metapneumovirus diagnostics market research report is one of a series of new reports from The Business Research Company that provides human metapneumovirus diagnostics market statistics, including human metapneumovirus diagnostics industry global market size, regional shares, competitors with a human metapneumovirus diagnostics market share, detailed human metapneumovirus diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the human metapneumovirus diagnostics industry. This human metapneumovirus diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The human metapneumovirus diagnostics market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.54 billion in 2025 at a compound annual growth rate (CAGR) of 10.3%. The growth observed in the historical period can be attributed to an increase in pediatric hospitalization rates due to respiratory infections, heightened awareness of viral respiratory pathogens, the initial adoption of molecular diagnostic tools, the expansion of public health surveillance programs, and greater funding for pediatric respiratory diseases.
The human metapneumovirus diagnostics market size is expected to see rapid growth in the next few years. It will grow to $0.79 billion in 2029 at a compound annual growth rate (CAGR) of 10.1%. The growth anticipated in the forecast period is driven by rising demand for early and accurate respiratory infection diagnostics, growing investments in point-of-care diagnostic solutions, expanding healthcare access in emerging markets, a global focus on pandemic preparedness, and greater integration of multiplex respiratory panels. Key trends in the forecast period include the development of automated and high-throughput diagnostic systems, a shift toward decentralized diagnostic models, the use of artificial intelligence in diagnostic interpretation, the increasing adoption of at-home testing kits, and growing collaboration between public and private diagnostic companies.
The increasing prevalence of respiratory infections is expected to drive growth in the human metapneumovirus diagnostics market. Respiratory infections, caused by viruses, bacteria, or other pathogens, affect the respiratory system, including the sinuses, throat, airways, and lungs. The rising prevalence can be linked to the exposure to harmful pollutants that irritate and weaken the respiratory tract, making it more susceptible to infections. Human metapneumovirus diagnostics help identify hMPV as the cause of respiratory infections, allowing for accurate treatment and better management. For example, in January 2025, the UK Health Security Agency reported that during the 2023-2024 season, respiratory infection rates in England peaked at 8.0 per 100,000 in weeks 50 and 52 of 2023, and rose further to 10.2 per 100,000 in week 4 of 2024, while acute respiratory infection incidents in closed settings reached 2,051, with most cases reported in care homes and hospitals. This growing prevalence of respiratory infections is fueling the expansion of the human metapneumovirus diagnostics market.
Leading companies in the human metapneumovirus diagnostics market are focusing on developing innovative solutions, such as respiratory polymerase chain reaction (PCR) diagnostic tools, to enhance molecular diagnostic capabilities for detecting a wide range of respiratory pathogens. A respiratory PCR diagnostic solution is a molecular testing method used to detect and identify respiratory pathogens by amplifying their genetic material with high sensitivity and specificity. For example, in March 2023, Jiangsu BioPerfectus Technologies Co., Ltd., a molecular diagnostic company based in China, launched its respiratory pathogen multiplex real-time PCR diagnostic kit. This solution is designed to simultaneously detect multiple respiratory pathogens with high accuracy and a rapid turnaround time, improving diagnostic efficiency in clinical and point-of-care settings. Its broad coverage and precise performance significantly aid timely clinical decision-making, particularly for managing respiratory infections with overlapping symptoms.
In February 2024, AstraZeneca plc, a pharmaceutical company based in the UK, acquired Icosavax Inc. for an undisclosed amount. With this acquisition, AstraZeneca aims to enhance its late-stage pipeline and expand its expertise in vaccines for respiratory conditions with high burdens, specifically advancing Icosavax's lead investigational combination vaccine candidate, IVX-A12, which targets both respiratory syncytial virus (RSV) and human metapneumovirus (hMPV). Icosavax Inc., a biotechnology company based in the US, focuses on developing vaccines, especially combination vaccines targeting respiratory viruses such as RSV and hMPV.
Major players in the human metapneumovirus diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Quest Diagnostics, Hologic Inc., QuidelOrtho Corporation, Bio-Rad Laboratories Inc., ARUP Laboratories, Qiagen NV, Diasorin, Luminex Corporation, bioMerieux, Seegene Inc., Cepheid, R-Biopharm AG, Certest Biotec, ZeptoMetrix, Xi'an Tianlong Science and Technology Co. Ltd, The Native Antigen Company, Hangzhou Testsea Biotechnology Co. Ltd., and Attogene.
North America was the largest region in the human metapneumovirus diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in human metapneumovirus diagnostics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the human metapneumovirus diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The human metapneumovirus diagnostics market consists of revenues earned by entities by providing services such as diagnostic testing services, clinical laboratory services, point-of-care testing services, home sample collection services, public health surveillance services, and contract research and testing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The human metapneumovirus diagnostics market also includes sales of sample collection devices, diagnostic data management tools, test validation kits, and safety and waste disposal systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Human Metapneumovirus Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on human metapneumovirus diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for human metapneumovirus diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The human metapneumovirus diagnostics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Reagents And Kits; Instruments
2) By Test Type: Molecular Diagnostics; Immunodiagnostics; Culture Based Methods; Other Test Types
3) By Technology: PCR-Based Diagnostics; Next-Generation Sequencing (NGS); Immunofluorescence Assays; Lateral Flow Assays; Microarray Technology; Other Advanced Technologies
4) By End-Use: Hospitals And Clinics; Diagnostic And Reference Laboratories; Academic And Research Institutions; Other End Users
Subsegments:
1) By Reagents And Kits: Sample Collection Kits; Nucleic Acid Extraction Kits; Viral Transport Media; Control Reagents
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Human Metapneumovirus Diagnostics Market Characteristics
3. Human Metapneumovirus Diagnostics Market Trends And Strategies
4. Human Metapneumovirus Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Human Metapneumovirus Diagnostics Growth Analysis And Strategic Analysis Framework
5.1. Global Human Metapneumovirus Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Human Metapneumovirus Diagnostics Market Growth Rate Analysis
5.4. Global Human Metapneumovirus Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Human Metapneumovirus Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Human Metapneumovirus Diagnostics Total Addressable Market (TAM)
6. Human Metapneumovirus Diagnostics Market Segmentation
6.1. Global Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents And Kits
Instruments
6.2. Global Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Molecular Diagnostics
Immunodiagnostics
Culture Based Methods
Other Test Types
6.3. Global Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
PCR-Based Diagnostics
Next-Generation Sequencing (NGS)
Immunofluorescence Assays
Lateral Flow Assays
Microarray Technology
Other Advanced Technologies
6.4. Global Human Metapneumovirus Diagnostics Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic And Reference Laboratories
Academic And Research Institutions
Other End Users
6.5. Global Human Metapneumovirus Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Sample Collection Kits
Nucleic Acid Extraction Kits
Viral Transport Media
Control Reagents
6.6. Global Human Metapneumovirus Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thermal Cyclers
Automated Analyzers
Nucleic Acid Extractors
Fluorescence Readers
7. Human Metapneumovirus Diagnostics Market Regional And Country Analysis
7.1. Global Human Metapneumovirus Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Human Metapneumovirus Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Human Metapneumovirus Diagnostics Market
8.1. Asia-Pacific Human Metapneumovirus Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Human Metapneumovirus Diagnostics Market
9.1. China Human Metapneumovirus Diagnostics Market Overview
9.2. China Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Human Metapneumovirus Diagnostics Market
10.1. India Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Human Metapneumovirus Diagnostics Market
11.1. Japan Human Metapneumovirus Diagnostics Market Overview
11.2. Japan Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Human Metapneumovirus Diagnostics Market
12.1. Australia Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Human Metapneumovirus Diagnostics Market
13.1. Indonesia Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Human Metapneumovirus Diagnostics Market
14.1. South Korea Human Metapneumovirus Diagnostics Market Overview
14.2. South Korea Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Human Metapneumovirus Diagnostics Market
15.1. Western Europe Human Metapneumovirus Diagnostics Market Overview
15.2. Western Europe Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Human Metapneumovirus Diagnostics Market
16.1. UK Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Human Metapneumovirus Diagnostics Market
17.1. Germany Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Human Metapneumovirus Diagnostics Market
18.1. France Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Human Metapneumovirus Diagnostics Market
19.1. Italy Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Human Metapneumovirus Diagnostics Market
20.1. Spain Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Human Metapneumovirus Diagnostics Market
21.1. Eastern Europe Human Metapneumovirus Diagnostics Market Overview
21.2. Eastern Europe Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Human Metapneumovirus Diagnostics Market
22.1. Russia Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Human Metapneumovirus Diagnostics Market
23.1. North America Human Metapneumovirus Diagnostics Market Overview
23.2. North America Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Human Metapneumovirus Diagnostics Market
24.1. USA Human Metapneumovirus Diagnostics Market Overview
24.2. USA Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Human Metapneumovirus Diagnostics Market
25.1. Canada Human Metapneumovirus Diagnostics Market Overview
25.2. Canada Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Human Metapneumovirus Diagnostics Market
26.1. South America Human Metapneumovirus Diagnostics Market Overview
26.2. South America Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Human Metapneumovirus Diagnostics Market
27.1. Brazil Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Human Metapneumovirus Diagnostics Market
28.1. Middle East Human Metapneumovirus Diagnostics Market Overview
28.2. Middle East Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Human Metapneumovirus Diagnostics Market
29.1. Africa Human Metapneumovirus Diagnostics Market Overview
29.2. Africa Human Metapneumovirus Diagnostics Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Human Metapneumovirus Diagnostics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Human Metapneumovirus Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Human Metapneumovirus Diagnostics Market Competitive Landscape And Company Profiles
30.1. Human Metapneumovirus Diagnostics Market Competitive Landscape
30.2. Human Metapneumovirus Diagnostics Market Company Profiles
30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Human Metapneumovirus Diagnostics Market Other Major And Innovative Companies
31.1. QuidelOrtho Corporation
31.2. Bio-Rad Laboratories Inc.
31.3. ARUP Laboratories
31.4. Qiagen NV
31.5. Diasorin
31.6. Luminex Corporation
31.7. bioMerieux
31.8. Seegene Inc.
31.9. Cepheid
31.10. R-Biopharm AG
31.11. Certest Biotec
31.12. ZeptoMetrix
31.13. Xi'an Tianlong Science and Technology Co. Ltd
31.14. The Native Antigen Company
31.15. Hangzhou Testsea Biotechnology Co. Ltd.
32. Global Human Metapneumovirus Diagnostics Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Human Metapneumovirus Diagnostics Market
34. Recent Developments In The Human Metapneumovirus Diagnostics Market
35. Human Metapneumovirus Diagnostics Market High Potential Countries, Segments and Strategies
35.1 Human Metapneumovirus Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Human Metapneumovirus Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Human Metapneumovirus Diagnostics Market In 2029 - Growth Strategies
